Abstract Library

#821 Incidence of Secondary Neoplasia in Patients with Neuroendocrine Tumor: An Analysis of the SwissNET Database

Introduction: NET are believed to be associated with an increased risk for secondary neoplasia. Previous studies suggest incidence rates between 7% and 46%.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Blank A, Iff S, Stettler C,

Keywords: NET, secondary neoplasia,

#656 Diagnosis and Work-Up of 72 Consecutive Patients with Neuroendocrine Neoplasms at a Swiss Tertiary Referral Center

Introduction: Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Gouffon M

Authors: Gouffon M, Larche M, Schwartzenbach C, Stettler C, Prior J,

Keywords: NEN, cohort,

#397 Swiss Neuroendocrine Tumor (SwissNET) Registry: Update After Three Years

Introduction: To improve epidemiological data on patients with neuroendocrine tumors (NETs) in Switzerland, the Swiss registry for NETs (SwissNET) was established in 2008. Here we present the current state of the registry in 2011.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Stettler C, Limacher A, Christ E, Wagner S, Pralong F,

Keywords: neuroendocrine tumors, registries, carcinoid tumor,

#170 Swiss Neuroendocrine Tumor (SwissNET) registry: Results after 30 Months

Introduction: The Swiss registry for NETs (SwissNET) was established in 2008 to improve epidemiological data on NET patients in Switzerland. Here the results after 30 months of follow-up are presented.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Stettler C, Allemann S, Christ E, Wagner S, Pralong F,

Keywords: neuroendocrine tumors, registries, carcinoid tumors ,